Elbit Med Tech Total Liabilities
Elbit Med Tech total liabilities. Based on the latest financial reports, Elbit Med Tech (EMTC) has total liabilities worth ILA522.00K ILA (≈ $1.40K USD) as of December 2022. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Elbit Med Tech liquidity resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Elbit Med Tech (2008–2022)
Total liabilities of Elbit Med Tech from 2008 to 2022. This chart illustrates how Elbit Med Tech's total liabilities have evolved over time, based on quarterly financial data. Explore Elbit Med Tech long-term investment intensity to see how much of total assets are deployed in long-term investments.
Elbit Med Tech Competitors by Total Liabilities
The table below lists competitors of Elbit Med Tech ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Vanquis Banking Group PLC
LSE:VANQ
|
UK | GBX3.45 Billion |
|
Heads UP Ventures Limited
NSE:HEADSUP
|
India | Rs297.60 Million |
|
Enova Mining Ltd
AU:ENV
|
Australia | AU$384.62K |
|
SaverOne 2014 Ltd. American Depositary Shares
NASDAQ:SVRE
|
USA | $4.35 Million |
|
Smartfren Telecom Tbk
JK:FREN
|
Indonesia | Rp21.74 Trillion |
|
Luminar Technologies Inc. Class A
NASDAQ:LAZRQ
|
USA | $608.34 Million |
|
Gaucho Group Holdings Inc
NASDAQ:VINO
|
USA | $10.85 Million |
|
Clasquin
PA:ALCLA
|
France | €203.60 Million |
Liability Composition Analysis (2008–2022)
This chart breaks down Elbit Med Tech's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Elbit Med Tech.
Liquidity & Leverage Metrics
Elbit Med Tech Total Liabilities Ratios Explained
Elbit Med Tech total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.33 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.02 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.02 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Elbit Med Tech's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Elbit Med Tech (2008–2022)
The table below shows the annual total liabilities of Elbit Med Tech from 2008 to 2022.
| Year | Total Liabilities | Change |
|---|---|---|
| 2022-12-31 | ILA522.00K ≈ $1.40K |
-7.45% |
| 2021-12-31 | ILA564.00K ≈ $1.51K |
-98.47% |
| 2020-12-31 | ILA36.97 Million ≈ $99.12K |
-26.77% |
| 2019-12-31 | ILA50.48 Million ≈ $135.34K |
+15.99% |
| 2018-12-31 | ILA43.52 Million ≈ $116.69K |
+2.47% |
| 2017-12-31 | ILA42.48 Million ≈ $113.87K |
+14.23% |
| 2016-12-31 | ILA37.18 Million ≈ $99.69K |
+9.35% |
| 2015-12-31 | ILA34.00 Million ≈ $91.16K |
+4.42% |
| 2014-12-31 | ILA32.56 Million ≈ $87.31K |
-3.70% |
| 2013-12-31 | ILA33.82 Million ≈ $90.66K |
-41.03% |
| 2011-12-31 | ILA57.35 Million ≈ $153.75K |
+65.68% |
| 2010-12-31 | ILA34.61 Million ≈ $92.80K |
-78.13% |
| 2009-12-31 | ILA158.28 Million ≈ $424.35K |
-14.28% |
| 2008-12-31 | ILA184.65 Million ≈ $495.03K |
-- |
About Elbit Med Tech
Elbit Medical Technologies Ltd, an investment holding company, engages in the research, development, production, and marketing of magnetic and focused imaging equipment in the United States, Europe, and internationally. The company is developing a magnetic resonance imaging guided focused ultrasound treatment equipment to address various oncology and gynecology indications, as well as neurologica… Read more